Adrienne Graves

Adrienne Graves

Directeur/Membre du Conseil chez OCULAR THERAPEUTIX, INC.

Fortune : 843 451 $ au 31/05/2026

71 ans
Health Technology
Commercial Services
Miscellaneous

Profil

Dr. Adrienne L.
Graves
is an Independent Director at Opus Genetics, Inc., an Independent Director at Harrow, Inc., an Independent Director at Ocular Therapeutix, Inc., an Independent Director at Qlaris Bio, Inc., a Chairman at Retinal Degeneration Fund, a Member at American Glaucoma Society, a Member at The Association for Research in Vision & Ophthalmology and a Member at Women in Ophthalmology, Inc. She is on the Board of Directors at Opus Genetics, Inc., Harrow, Inc., Osanni Bio, Inc., G-Metrics GmbH, Ocular Therapeutix, Inc., JelliSee Ophthalmics, Inc., NVasc, Inc., The Foundation Fighting Blindness, Inc., Qlaris Bio, Inc., American Academy of Ophthalmology, Inc., The American Society of Cataract & Refractive Surgery, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation, American Society of Cataract & Refractive Surgery Foundation, Himalayan Cataract Project, KeepYourSight Foundation, Pan-American Ophthalmological Foundation and Retina Global.
Dr. Graves was previously employed as a Chairman by IVERIC bio, Inc., a Non-Executive Director by Oxurion NV, an Independent Director by Greenbrook TMS, Inc., an Independent Director by Surface Ophthalmics, Inc., an Independent Director by Nicox SA, an Independent Director by Akorn, Inc., an Independent Director by Aerpio Therapeutics, Inc., an Independent Director by Encore Vision, Inc., an Independent Director by Trukera Medical, a Vice President-Clinical Affairs by Santen, Inc., a Director-International Ophthalmology by Alcon Laboratories, Inc., and a Co-Founder by Ophthalmic Women Leaders.
She also served on the board at Opus Genetics, Inc. /OLD/, TherOptix, Inc., Nicox Ophthalmics, Inc., Envisia Therapeutics, Inc., Aerpio Pharmaceuticals, Inc. and Ophthalmic World Leaders.
She received her undergraduate degree from Brown University and a doctorate degree from the University of Michigan.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/04/2026 127 514 ( 0,16% ) 555 961 $ 31/05/2026
31/03/2026 28 000 ( 0,01% ) 252 280 $ 31/05/2026
18/05/2026 1 000 ( 0% ) 35 210 $ 31/05/2026

Postes actifs de Adrienne Graves

SociétésPosteDébut
OCULAR THERAPEUTIX, INC. Directeur/Membre du Conseil 10/07/2023
HARROW, INC. Directeur/Membre du Conseil 26/01/2024
OPUS GENETICS, INC. Directeur/Membre du Conseil 22/10/2024
Retina Global
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/01/2023
Président 21/07/2022
Directeur/Membre du Conseil 01/01/2021

Anciens postes connus de Adrienne Graves

SociétésPosteFin
NICOX SA Directeur/Membre du Conseil 27/02/2024
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Adrienne Graves

Formation de Adrienne Graves

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

40

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées40

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Pan-American Ophthalmological Foundation

Commercial Services

Commercial Services

Miscellaneous

Commercial Services

Ophthalmic Women Leaders

Health Technology

Health Technology

Commercial Services

American Academy of Ophthalmology Foundation

Commercial Services

Electronic Technology

Health Services

Miscellaneous

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Miscellaneous

Health Technology

Electronic Technology

Health Technology

Health Technology

Retina Global

Commercial Services

Health Technology

Ophthalmic World Leaders

Commercial Services

  1. Bourse
  2. Insiders
  3. Adrienne Graves
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT